CEO replacement, page-2

Don't hold your breath @col69, what a year to year debacle here.

2/6/21 - $1.765
2/6/22 - $0.705

Loss on SP of $1.06 or 60% . Its going to take an extraordinary BOD to gain the 150% to push the SP back to one year ago.

From the chair at 2019 AGM.
Good afternoon,
On behalf of the Starpharma Board, it is with great pleasure that I welcome you to
the 2019 Annual General Meeting.
Starpharma’s commercial strategy is now yielding a deep portfolio of high value
products and partnerships. Each of them has not only great potential for improving
patient health but also creating significant value for shareholders. We anticipate
further additions to this portfolio of products on a yearly basis.

It is remarkable for a company of our size and stage of development to have a portfolio featuring two
marketed products and another four exciting clinical stage assets, each of which has
the potential to generate significant revenue and transform the company.

Indeed, the next three years should prove to be very exciting for shareholders.

https://starpharma.com/assets/asxannouncements/191121%20AGM%20Chairman%20address%20and%20CEO%20presentation%20final.pdf